AR208545A1 - Procedimiento para la preparacion de nuevas s,s-dioxidos de 1-t-alquil-3-(4,5-dihidro-3-tienil o 3-tietil)ureas - Google Patents

Procedimiento para la preparacion de nuevas s,s-dioxidos de 1-t-alquil-3-(4,5-dihidro-3-tienil o 3-tietil)ureas

Info

Publication number
AR208545A1
AR208545A1 AR258396A AR25839675A AR208545A1 AR 208545 A1 AR208545 A1 AR 208545A1 AR 258396 A AR258396 A AR 258396A AR 25839675 A AR25839675 A AR 25839675A AR 208545 A1 AR208545 A1 AR 208545A1
Authority
AR
Argentina
Prior art keywords
tiethyl
thenyl
dioxides
ureas
dihydro
Prior art date
Application number
AR258396A
Other languages
English (en)
Spanish (es)
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of AR208545A1 publication Critical patent/AR208545A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR258396A 1974-04-17 1975-04-16 Procedimiento para la preparacion de nuevas s,s-dioxidos de 1-t-alquil-3-(4,5-dihidro-3-tienil o 3-tietil)ureas AR208545A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
AR208545A1 true AR208545A1 (es) 1977-02-15

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
AR258396A AR208545A1 (es) 1974-04-17 1975-04-16 Procedimiento para la preparacion de nuevas s,s-dioxidos de 1-t-alquil-3-(4,5-dihidro-3-tienil o 3-tietil)ureas

Country Status (21)

Country Link
US (1) US4009847A (enExample)
JP (1) JPS50148349A (enExample)
AR (1) AR208545A1 (enExample)
CA (1) CA1047042A (enExample)
CH (1) CH611292A5 (enExample)
DD (1) DD117223A5 (enExample)
DE (1) DE2516554A1 (enExample)
DK (1) DK164175A (enExample)
ES (1) ES436648A1 (enExample)
FI (1) FI751128A7 (enExample)
FR (1) FR2267773B1 (enExample)
GB (1) GB1461209A (enExample)
HU (1) HU173052B (enExample)
IE (1) IE41143B1 (enExample)
IL (1) IL47095A (enExample)
LU (1) LU72306A1 (enExample)
NL (1) NL7504570A (enExample)
NO (1) NO144071C (enExample)
PH (1) PH11722A (enExample)
SE (1) SE417965B (enExample)
YU (1) YU96075A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
IL144144A0 (en) * 1999-01-13 2002-05-23 Bayer Ag Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2393900T3 (es) * 2001-12-03 2012-12-28 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
SI1478358T1 (sl) * 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
PT1580188E (pt) * 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
JP4860474B2 (ja) * 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
CL2004001834A1 (es) * 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
CN101010315A (zh) * 2004-04-30 2007-08-01 拜耳制药公司 用于治疗癌症的取代的吡唑基脲衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
US4009847A (en) 1977-03-01
CA1047042A (en) 1979-01-23
NO144071C (no) 1981-06-17
DD117223A5 (enExample) 1976-01-05
YU96075A (en) 1983-04-27
NL7504570A (nl) 1975-10-21
DE2516554A1 (de) 1975-10-30
SE417965B (sv) 1981-04-27
NO751351L (enExample) 1975-10-20
IE41143L (en) 1975-10-17
IL47095A0 (en) 1975-06-25
PH11722A (en) 1978-05-30
AU8013575A (en) 1976-10-21
ES436648A1 (es) 1977-08-01
FR2267773A1 (enExample) 1975-11-14
HU173052B (hu) 1979-02-28
FI751128A7 (enExample) 1975-10-18
IL47095A (en) 1978-03-10
LU72306A1 (enExample) 1976-03-17
IE41143B1 (en) 1979-10-24
FR2267773B1 (enExample) 1978-08-18
GB1461209A (en) 1977-01-13
DK164175A (da) 1975-10-18
NO144071B (no) 1981-03-09
JPS50148349A (enExample) 1975-11-27
SE7503523L (sv) 1975-10-20
CH611292A5 (enExample) 1979-05-31

Similar Documents

Publication Publication Date Title
AR208545A1 (es) Procedimiento para la preparacion de nuevas s,s-dioxidos de 1-t-alquil-3-(4,5-dihidro-3-tienil o 3-tietil)ureas
AR211097A1 (es) Procedimiento para la preparacionde nuevos derivados de 3-(carbamil o tiocarbamil)-sulfamido-piridina-4-sustituida.
AR210990A1 (es) Procedimiento para preparar derivados de 1,1-dihideoperflujoroalcobenzamidas n-pirrolidin- o piperidin- sustituidas
AR207559A1 (es) Procedimiento para la preparacion de (n'-alquiltioureidoetil)metilsulfoxidos heterociclicos)
AR193590A1 (es) Procedimiento para la preparacion de 2,2'-metilendifenoles sustituidos
AR207766A1 (es) Procedimiento para la preparacion de 6,7-dimetoxi-4-amino-2-(4-(2-furoil)-piperazin-1-il)quinazolina
AR210116A1 (es) Procedimiento para la produccion de nuevos 4-fenilsulfinil-fenilguanidinas sustituidas,4-fenilsulfonilfenilguanidinas sustituidas,5-fenilsulfinilfenilguanidinas sustituidas y 5-fenilsulfonilfenilguanidinas sustituidas
AR218436A1 (es) Procedimiento para la preparacion de derivados de 2(o 4)-hidroxipolihaloisopropil fenil ureas
AR206626A1 (es) Procedimiento para la sintesis de la 2,3,3-trimetil indolenina
MX3514E (es) Procedimiento para la preparacion de derivados de 1,3 tiazolidinas
AR220126A1 (es) Procedimiento para la preparacion de 1,2,4-benzotiadiazina-1 oxido 3-amino-1-sustituido
AR208104A1 (es) Um procedimiento para la preparacion de nuevas 6-metil-8-beta-(substituida)metilergolinas
AR211100A1 (es) Procedimiento para la preparacion de 3-metilpirazol-5-carboxilatos.
AR194249A1 (es) Procedimiento para la preparacion de n-(2,4-dihalogen-s-triacin-6-il)ureas
AR206621A1 (es) Procedimiento para la preparacion de n-(2-pirrolidinilalquil)-benzamidas substituidas
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
AR216894A1 (es) Procedimiento para la obtencion de derivados de 1,3-diisocianatopropano y dichos derivados
AR213411A1 (es) Procedimiento para la preparacion de 2,6-metano-benzazocinas
AR204438A1 (es) Procedimiento para la preparacion de 2-hidroxi-3-alquilamino propoxi-2o3-azidofenoles
AR206143A1 (es) Procedimiento para la preparacion de compuestos de 1 - t - alquil - 3 - (2,5 - dihidro - 5 - oxo - 3 - furil) ureas
AR206020A1 (es) Procedimiento para la preparacion de compuestos de 1-t-alquil-3-(3-oxo-ciclohexen-1-il) ureas
AR208532A1 (es) Un procedimiento para la preparacion de derivados de 3,4,6-tri-0-alcanoilo inferior-2-deoxi-2-nicotinamido-1-0-nicotinoil-glucopiranosa
AR205256A1 (es) Procedimiento para la produccion de nuevas n'-4-acilaminofenil)-n, n-dimetilacetamidinas
AR212235A1 (es) Procedimiento para la preparacion de imidas del acido 5-endo-(3-indolecarboniloxi)-n-(aminoquilo inferior)-biciclo(3.3.1)-heptano-2,3-di-endo-carboxilico
AR219307A1 (es) Procedimiento para la preparacion de derivados de 2-benxoil-n alpha-glicil-glicil o n alpha-a-fenilalanilglicilanilida